Byotrol Share Discussion Threads

[shroder] 20/7/2015 09:37

Yes, true unfortunately, Tesco wafer thin margins too I expect.

[mudbath] 20/7/2015 09:28

Also available at Sainsburys Shroder.
Unfortunately it will be Petface which garners most of the margin.

[shroder] 20/7/2015 09:20

Several new product lines introduced, including a range of pet grooming kits for Argos.

[mudbath] 04/7/2015 11:39

Far from it maxk; rather like Byotrols apparent proximity to reporting positive EBITDA.

[maxk] 04/7/2015 09:34

£5.5k ish, is it significant?

[mudbath] 04/7/2015 09:22

As I said, Ruffer now down to 21%.

[wisecat2] 01/7/2015 10:54

Its not Ruffer but a discretionary client. Hopefully a one off ( size indicates that)

[mudbath] 01/7/2015 10:37

Ruffer now down to 21% and yet the share price is firm(ish),so someone somewhere ,besides BB,must be keen.

[maxk] 26/6/2015 19:58

100k at mid, how can you tell?

[mudbath] 26/6/2015 19:50

Correct,brownson.

I really struggle to call this one.

[brownson] 24/6/2015 14:42

big sell though

[mudbath] 24/6/2015 11:44

Indeed Shroder.

Strong buying again this morning;even though the trades show as sells.
It's all looking a smidge more hopeful,imo.

[shroder] 23/6/2015 15:22

Afternoon mud, let's hope it's not blind faith :)

[mudbath] 23/6/2015 10:13

I admire your faith in the BOD Shroder.
Let us hope that one day it might translate into BYOT achieving a positive EBITDA.
Imo, an early loss of its independence would benefit all concerned,for the Company is just too under capitalised for it to progress against the many headwinds.
As it is,the years just ebb away,whilst that elusive profitability remains firmly "just" over the horizon,despite being alluded to as "achievable" in now elapsed trading periods by the men you hold in such high esteem.

"We will continue to build on our "legacy" business areas of Food, Health, Industrial and Pet. The current contribution from these businesses, together with the contribution from our newly constituted Consumer Division, has brought us close to the point of monthly break-even." (April 2014)

Whereas the current perceived scenario has shifted to,

"Whilst the year in review was by no means easy, we are pleased with what we have achieved. The financial performance is not yet where we need it to be, but it is steadily improving and the quality of our products is improving in leaps and bounds." (April 2015)

The item in the recent prelims which made my blood run cold was the CEO's comment,

"On the other hand it will not be lost on our shareholders that a single big win will have a very beneficial effect on our finances."

Chasing that elusive "big one" has proven the death knell for many a company.

[shroder] 20/6/2015 12:18

Sometimes investors react to the share price rather than the accounts themselves.

If you view the accounts from the stand point of a new company (since merger) David's team have performed a sterling job.

We seem to have found our way into the NHS without really having a major RNS stating this, yes it will be slow but we have a good partner with ISS who are well established.

Rentokil agreement has been rejigged and appears back on track.

The consumer range which took a hit because of supermarket discounting has started to reverse, extended contract too.

"The UK supermarket environment is improving – branded player promotions are lessening and high quality own-label activity is increasing. On this basis we have now agreed to extend by a further 12 months the licences in UK trigger sprays with Robert McBride plc"

..and Tesco Europe

"We continue to work very well in in partnership with key accounts, namely pet speciality retailer Pets at Home and branded distributor Petface, the latter of which has now launched Byotrol products in several new territories with Tesco Central Europe"

The reformulations are done, now the company can focus on all important sales.

"Having completed the majority of technical work, we are now turning more aggressively to sales, using our own resources and those from alliances, agents and exclusive partnerships. We would certainly like to expand our own in-house sales force substantially, but we will only increase overheads as sales and margins allow."

..and as previously mentioned, Solvay.

"New marketing initiatives in Healthcare (particularly via a joint marketing agreement with ISS Facilities Services - Healthcare) and Consumer (via a series of technical development relationships with large chemical companies, including Solvay, the international chemical group)"

But apart from that they have made no progress at all.

imho

[battlebus2] 19/6/2015 15:25

Yes all very good for us shroder, sorry i didn't hold my shares in pets....

[shroder] 19/6/2015 15:22

Pets at Home just about to break 300p

"Petcare

Year on year revenues increased markedly, by 30%, from GBP721k to GBP938k, with gross profit increasing by 40% from GBP209k to GBP 293k.

We continue to work very well in in partnership with key accounts, namely pet speciality retailer Pets at Home and branded distributor Petface, the latter of which has now launched Byotrol products in several new territories with Tesco Central Europe.

Exports continue to grow steadily and we are starting to see progress in South Africa with a new licencee, Pharma Marketing International, who now sell the Pet Patrol brand into retail multiples; Spar, Game and Pick n Pay."

[battlebus2] 18/6/2015 16:59

Feels great to be back above 4p :))

[shroder] 16/6/2015 17:17

There's one or two interesting bits but not really had the time to go through in any detail.

Some interest today perhaps ?

[mudbath] 16/6/2015 12:39

A M/C for SOLB of 10 billion euros certainly makes the pulse race.

[qs99] 16/6/2015 11:50

fascinating read, but not sure I will be buying in just yet,....cash burn too great and sales/profits increase not fast enough to offset...the deficit on P&L reserves highlights the lack of success with this company...IMO!

[shroder] 16/6/2015 11:37

"A fortuitous outcome from our efforts in developing new formulations is that we have improved the cleaning capability of our consumer liquids. Whereas our previous focus was on the anti-bacterial properties, we now have a world class product with superior cleaning properties, developed in conjunction with the international chemical group Solvay, which is also now supporting us in the commercialisation effort."

[mudbath] 16/6/2015 10:31

At least cash usage fell to circa £50k per month over the past six months.
If this could be halved to say £25k pm then cash would not run out until the second half.
I also have a concern over inventories and debtors.If the formulations are needing to be changed,this might generate unusable stock both in respect of held and sold product .